دورية أكاديمية

Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial.

التفاصيل البيبلوغرافية
العنوان: Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial.
المؤلفون: Taleb, Nadine, Carpentier, André C., Messier, Virginie, Ladouceur, Martin, Haidar, Ahmad, Rabasa-Lhoret, Rémi
المصدر: Diabetes Care; Jul2019, Vol. 42 Issue 7, pe107-e109, 3p
مصطلحات موضوعية: ARTIFICIAL pancreases, TYPE 2 diabetes, CROSSOVER trials, INSULIN, TYPE 1 diabetes, INSULIN derivatives, GLUCAGON-like peptides, EMPAGLIFLOZIN
مستخلص: The article discusses a study on the efficacy of artificial pancreas (AP) in type 2 diabetes (T2D) patients using intensive insulin therapy. Results showed the applicability of AP in a controlled setting for T2D patients on intensive insulin, and the possible translation of improved glucose control into improved time for targeting a range of complications. Also noted is the need to weigh the technology's benefits against the costs and complexity of AP systems.
قاعدة البيانات: Complementary Index
الوصف
تدمد:01495992
DOI:10.2337/dc18-2406